Biotech Industry Sees Dollar Signs In Jobs Bill

Law360, New York (March 9, 2012, 6:46 PM EST) -- The biotech industry is cheering the passage Thursday of a jobs creation bill in the House, saying provisions that delay reporting requirements for newly public companies would make it easier for small, struggling biotech firms to raise money by going public.

The so-called JOBS bill, for Jumpstart Our Business Startups, includes an “on-ramp” provision to make initial public offerings more attractive to small companies.

Under the bill, companies that go public with less than $1 billion in annual revenue could delay hiring an auditor to keep...
To view the full article, register now.